What!!!!! You're saying Mulroy has to move on????? All this time I thought you were his nephew. You would do well to get rid of your strong buy recommendation. I doubt you have been buying and Hold will keep the ridicule off.
So much promise in MACK with so little leadership.
They could turn water into wine and the stock will not go up. This is a poorly managed company and as you can see news does not help. They should fast track Mulroy out the door.
I would love to buy back into this company as there is a lot of shots on goal. However, I like to buy competent management and that just does not exist in Cambridge.
I would like to have Wednesday's Wall Street tomorrow also but inside buying is a useless indicator.
All they have to do is run the company right and not lie to its shareholders. Stop being naive. You drink too
much MACK Kool Aid.
Tomorrow.....Great sale on bridges!
No matter what SCI says he is missing the big picture....they could cure cancer and the stock would go down....management my boy...Hey where is Michael Porter and hios wallet..think he would be loading up down here...
Check the price this morning...and Mulroy still has a job..amazing
you have to have a huge paper loss so do not criticize another's action. you have been a zealot for this stock. half the posts on this board are from you. you kept arguing with me about the management of MACK forever. you have a ceo that has been lying to shareholders and has driven what was once a great opportunity into a joke. you may luck out as some drug company should come in an make a bid...throwaway i assume, but even with what seems to be a decent understanding of this company your judgement error on management makes you out to be fool you constantly portray. mulroy should be fired but sadly crocker et al seem as useless as he.
90% of options expire worthless...and the open interest is nothing compared to the short interest...it may all be boxed shorts by institutions and management can't short or lend their shares..seeing the borrowing cost is low I would say all the shorts are boxed which says institutions are not afraid of a take out and have either a large gain or loss they do not want to take...maybe the guy who thinks they are hedging the price of eggs has a good theory...but having 52% of your shares short is quite amazing...the management holds a lot of stock and seems content to keep their company. boring business ...
What do you want them to say???? They disclosed at ot..1000 calls to the existing 11 centers. a lot who left after they found out there was no reimbursement. They admit they need a payer and are working on it. They have a lot of surgeons interested and this is a gold mine for them.
Scam??? You are an idiot..you do not even know what the company does.
No...may be some smart hedge funds but right here it would not take much to buy the company. The price now is just the specs leaving...Amazing they can't get GSK to do a small trial on a new indication....I think Gladney will get coverage and sooner than we think. But we have not been around that long so the data that is going to be published soon could be crucial. Insulin costs $10000 a year and you would think there is some smart insurance operation that could figure out the benefits of our device.
1000 calls in the centers was a great data point but this is all about reimbursement.
I hope they are not still charging $15000 as the payers will back off. This stock sadly is now a lottery ticket..great technology in an space that has enormous potential. Gladney seems to be doing a great job as far as I am concerned. I suspect they have 3 more quarters of money....so it is up to the reimbursement folks.
There was never a $20 PPS bid....that is a material fact and should have been disclosed.. Baxalta never bid for the company and why would they. They got what they wanted.